Kybella FDA Approved for Double Chin Reduction

Posted on September 28, 2015 by adminmms

Kybella FDA Approved for Double Chin Reduction
One of the common aesthetic concerns that may affect both men and women almost equally is the accumulation of unwanted fat tissue in the submental area below the chin. This causes the appearance of a double chin and a poorly defined chin profile. The condition can be corrected with liposuction plastic surgery, but not every patient may be inclined to choose an elective surgery procedure.
Kybella injectable treatment to reduce double chin is a new non-surgical solution that is creating waves in the field of facial aesthetics. As an experienced cosmetic surgeon, Dr. Gary Motykie recommends Kybella as an effective option for patients who wish to get rid of double chin appearance without surgery. Patients in Beverly Hills, West Hollywood, Los Angeles, and surrounding communities have an opportunity to receive Kybella treatment from Dr. Motykie.

Safe and Proven Solution

Until now, patients hardly had an effective option to reduce double chin without plastic surgery. However, now Kybella has emerged as the first and only non-surgical treatment that has been approved by the FDA for the reduction of submental fat. According to Keith Leonard, President and CEO of Kythera, the treatment has been adequately tested for safety and efficacy, and aesthetic experts are willing to recommend it following its FDA approval.
“For the first time, people have access to an FDA-approved, non-surgical treatment for submental fullness, a condition that can negatively impact the overall appearance of the face and can result in a person feeling older and heavier. With Kybella, physicians can offer a clinically-proven treatment that is customized to the patient and their treatment goals for an improved chin profile,” says Leonard.
Dr. Motykie focuses on cutting edge solutions to ensure that his patients have the privilege to receive the best treatments that deliver awesome results in a minimally invasive manner. As a leading cosmetic surgeon, Dr. Motykie supports Kybella as a treatment of choice for patients looking to reduce double chin without surgery. He receives patients from Beverly Hills, West Hollywood, Los Angeles, and nearby areas.

High Patient Satisfaction

Kybella’s efficacy was tested through an extensive clinical development program that spanned more than 20 clinical studies and over 2,600 patients across the world. In the pivotal Phase III studies, it was found that more than 68% of the patients responded favorably to Kybella treatment. They not only reported aesthetic improvement by way of reduction of submental fat, but also indicated emotional benefits due to an improved chin and facial profile.

Procedure

Kybella injections are placed directly in the submental fat areas below the chin. The first treatment session may last for about 30 minutes, while the remaining sessions may be of 15 to 20 minutes duration. Most patients may need two to four treatments to achieve satisfactory outcomes. In severe cases, the surgeon may recommend up to six treatment sessions of Kybella.
The President of the American Society for Aesthetic Plastic Surgery (ASAPS), Dr. Michael C. Edwards, hails Kybella as a revolutionary treatment with promising potential for the facial aesthetics industry. Dr. Edwards recommends that patients should choose a qualified surgeon to ensure the sharpest and most impressive results with Kybella injectable treatment.
Click here for Virtual Consultation

To see more services and treatments provided by Plastic Surgeon, Dr. Motykie in Beverly Hills | Los Angeles and his team please visit: